Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

Maria Serova, Armand de Gramont, Annemilaï Tijeras‐Raballand, Célia Dos Santos, María E. Riveiro, Khémaies Slimane, Sandrine Faivre, Éric Raymond

Cancer Chemotherapy and Pharmacology · 2013 · 42 citations · 25 references

Concepts

References

25